Effect of vitamin K intake on the stability of oral anticoagulant treatment: Dose-response relationships in healthy subjects

Blood

Volumn 104, Issue 9, 2004, Pages 2682-2689

  Schurgers, Leon J ^a   Shearer, Martin J ^b   Hamulyák, Karly ^b   Stöcklin, Elisabeth ^b   Vermeer, Cees ^b  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACENOCOUMAROL; ANTICOAGULANT AGENT; BLOOD CLOTTING FACTOR 7; OSTEOCALCIN; PROTHROMBIN; VITAMIN K GROUP;

ADULT; ARTICLE; BIOAVAILABILITY; BLOOD CLOTTING; BROCCOLI; CARBOXYLATION; CHEESE; DOSE RESPONSE; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENCE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; IMMUNOASSAY; MALE; NORMAL HUMAN; PRIORITY JOURNAL; SPINACH;

EID: 7244258903     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2004-04-1525     Document Type: Article

References (51)

1. Hirsh J, Fuster V, Ansell J, Halperin JL. American Heart Association/American College of Cardiology Foundation guide to warfarin therapy. Circulation. 2003;107:1692-1711.
2. Furie B, Bouchard BA, Furie BC. Vitamin K-dependent biosynthesis of gamma-carboxyglutamic acid. Blood. 1999;93:1798-1808.
3. Simmelink MJ, de Groot PG, Derksen RH, Fernandez JA, Griffin JH. Oral anticoagulation reduces activated protein C less than protein C and other vitamin K-dependent clotting factors. Blood. 2002;100:4232-4233.
4. Vermeer C. Gamma-carboxyglutamate-containing proteins and the vitamin K-dependent carboxylase. Biochem J. 1990;266:625-636.
5. Price PA. Gla-containing proteins of bone. Connect Tissue Res. 1989;21:51-57.
6. Bell RG. Metabolism of vitamin K and prothrombin synthesis: anticoagulants and the vitamin K-epoxide cycle. Fed Proc. 1978;37:2599-2604.
7. Suttie JW. Recent advances in hepatic vitamin K metabolism and function. Hepatology. 1987;7:367-376.
8. Vermeer C, Hamulyak K. Pathophysiology of vitamin K-deficiency and oral anticoagulants. Thromb Haemost. 1991;66:153-159.
9. Wallin R, Gebhardt O, Prydz H. NAD(P)H dehydrogenase and its role in the vitamin K (2-methyl-3-phytyl-1,4-naphthaquinone)-dependent carboxylation reaction. Biochem J. 1978;169:95-101.
10. Wallin R. Vitamin K antagonism of coumarin anticoagulation: a dehydrogenase pathway in rat liver is responsible for the antagonistic effect. Biochem J. 1986;236:685-693.
11. Wallin R, Martin LF. Warfarin poisoning and vitamin K antagonism in rat and human liver: design of a system in vitro that mimics the situation in vivo. Biochem J. 1987;241:389-396.
12. Booth SL, Centurelli MA. Vitamin K: a practical guide to the dietary management of patients on warfarin. Nutr Rev. 1999;57:288-296.
13. Kalra PA, Cooklin M, Wood G, O'Shea GM, Holmes AM. Dietary modification as cause of anticoagulation instability [letter]. Lancet. 1988;2:803.
14. Kempin SJ. Warfarin resistance caused by broccoli [letter]. N Engl J Med. 1983;308:1229-1230.
15. Oren B, Shvartzman P. Unsuspected source of vitamin K in patients treated with anticoagulants: a case report. Fam Pract. 1989;6:151-152.
16. Michaelson R, Kempin SJ, Navia B, Gold JW. Inhibition of the hypoprothrombinemic effect of warfarin (Coumadin) by Ensure Plus, a dietary supplement. Clin Bull. 1980;10:171-172.
17. Karlson B, Leijd B, Hellstrom K. On the influence of vitamin K-rich vegetables and wine on the effectiveness of warfarin treatment. Acta Med Scand. 1986;220:347-350.
18. Pedersen FM, Hamberg O, Hess K, Ovesen L. The effect of dietary vitamin K on warfarin-induced anticoagulation. J Intern Med. 1991;229:517-520.
19. Ridker PM, Goldhaber SZ, Danielson E, et al. Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism. N Engl J Med. 2003;348:1425-1434.
20. Food and Nutrition Board, Institute of Medicine. In: Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc. Washington, DC: National Academy Press; 2001:162-196.
21. Shearer MJ. Role of vitamin K and Gla proteins in the pathophysiology of osteoporosis and vascular calcification. Curr Opin Ciin Nutr Metab Care. 2000;3:433-438.
22. Sato Y, Honda Y, Kunoh H, Oizumi K. Long-term oral anticoagulation reduces bone mass in patients with previous hemispheric infarction and nonrheumatic atrial fibrillation. Stroke. 1997;28:2390-2394.
23. Caraballo PJ, Heit JA, Atkinson EJ, et al. Long-term use of oral anticoagulants and the risk of fracture. Arch Intern Med. 1999;159:1750-1756.
24. Resch H, Pietschmann P, Krexner E, Willvonseder R. Decreased peripheral bone mineral content in patients under anticoagulant therapy with phenprocoumon. Eur Heart J. 1991;12:439-441.
25. Fiore CE, Tamburino C, Foti R, Grimaldi D. Reduced axial bone mineral content in patients taking an oral anticoagulant. South Med J. 1990;83:538-542.
26. Schurgers LJ, Vermeer C. Differential lipoprotein transport pathways of K-vitamins in healthy subjects. Biochim Biophys Acta. 2002;1570:27-32.
27. Hirsh J, Fuster V. Guide to anticoagulant therapy, part 2: oral anticoagulants. American Heart Association. Circulation. 1994;89:1469-1480.
28. Belle M, Brebant R, Guinet R, Leclercq M. Production of a new monoclonal antibody specific to human des-gamma-carboxyprothrombin in the presence of calcium ions: application to the development of a sensitive ELISA-test. J Immunoassay. 1995;16:213-229.
29. Schurgers LJ, Vermeer C. Determination of phylloquinone and menaquinones in food: effect of food matrix on circulating vitamin K concentrations. Haemostasis. 2000;30:298-307.
30. 1) content of foods. Br J Nutr. 2000;83:389-399.
31. 1 (phylloquinone) content of foods: a provisional table. J Food Comp Anal. 1993;6:109-120.
32. 1) content of foods in the U.S. Food and Drug Administration's total diet study. J Agric Food Chem. 1995;43:1574-1579.
33. Almquist HJ, Mecchi E, Klose AA. Estimation of the anti-haemorrhagic vitamin. Biochem J. 1938;32:1897-1903.
34. Almquist HJ. Relation of prothrombin level to vitamin K intake. Arch Biochem Biophys. 1952;35:463-465.
35. Frick PG, Riedler G, Brogli H. Dose response and minimal daily requirement tor vitamin K in man. J Appl Physiol. 1967;23:387-389.
36. Price PA, Kaneda Y. Vitamin K counteracts the effect of warfarin in liver but not in bone. Thromb Res. 1987;46:121-131.
37. Vermeer C, Jie KS, Knapen MH. Role of vitamin K in bone metabolism. Annu Rev Nutr. 1995;15:1-22.
38. Shearer MJ, Barkhan P, Webster GR. Absorption and excretion of an oral dose of tritiated vitamin K1 in man. Br J Haematol. 1970;18:297-308.
39. Shearer MJ, Mallinson CN, Webster GR, Barkhan P. Clearance from plasma and excretion in urine, faeces and bile of an intravenous dose of tritiated vitamin K 1 in man. Br J Haematol. 1972;22:579-588.
40. Garber AK, Binkley NC, Krueger DC, Suttie JW. Comparison of phylloquinone bioavailability from food sources or a supplement in human subjects. J Nutr. 1999;129:1201-1203.
41. Shearer MJ, McBurney A, Breckenridge AM, Barkhan P. Effect of warfarin on the metabolism of phylloquinone (vitamin K1): dose-response relationships in man. Clin Sci Mol Med. 1977;52:621-630.
42. Shearer MJ, McBurney A, Barkhan P. Studies on the absorption and metabolism of phylloquinone (vitamin K1) in man. Vitam Horm. 1974;32:513-542.
43. Shearer MJ, Bach A, Kohlmeier M. Chemistry, nutritional sources, tissue distribution and metabolism of vitamin K with special reference to bone health. J Nutr. 1996;126:1181s-1186s.
44. Booth SL, Pennington JA, Sadowski JA. Food sources and dietary intakes of vitamin K-1 (phylloquinone) in the American diet: data from the FDA Total Diet Study. J Am Diet Assoc. 1996;96:149-154.
45. Thane CW, Paul AA, Bates CJ, Bolton-Smith C, Prentice A, Shearer MJ. Intake and sources of phylloquinone (vitamin K1): variation with sociodemographic and lifestyle factors in a national sample of British elderly people. Br J Nutr. 2002;87:605-613.
46. Schurgers LJ, Geleijnse JM, Grobbee DE, et al. Nutritional intake of vitamins K-1 (phylloquinone) and K-2 (menaquinone) in The Netherlands. J Nutr Environm Med. 1999;9:115-122.
47. Booth SL, Suttie JW. Dietary intake and adequacy of vitamin K. J Nutr. 1998;128:785-788.
48. Gijsbers BL, Jie KS, Vermeer C. Effect of food composition on vitamin K absorption in human volunteers. Br J Nutr. 1996;76:223-229.
49. Booth SL, Lichtenstein AH, Dallal GE. Phylloquinone absorption from phylloquinone-fortified oil is greater than from a vegetable in younger and older men and women. J Nutr. 2002;132:2609-2612.
50. Kaneki M, Hedges SJ, Hosoi T, et al. Japanese fermented soybean food as the major determinant of the large geographic difference in circulating levels of vitamin K2: possible implications for hip-fracture risk. Nutrition. 2001;17:315-321.
51. Kudo T. Warfarin antagonism of natto and increase in serum vitamin K by intake of natto. Artery. 1990;17:189-201.